MediciNova, Inc.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US58468P2065
USD
1.46
0.01 (0.69%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Oramed Pharmaceuticals, Inc.
Abeona Therapeutics, Inc.
Eton Pharmaceuticals, Inc.
Nektar Therapeutics
Esperion Therapeutics, Inc.
ProQR Therapeutics NV
Talaris Therapeutics, Inc.
Ocugen, Inc.
Inovio Pharmaceuticals, Inc.
MediciNova, Inc.
Reviva Pharmaceuticals Holdings, Inc.

Why is MediciNova, Inc. ?

Icon
Unrated Stock - No Analysis Available
stock-recommendationReal-Time Research Report

Verdict Report

Icon
No Data Found

Is MediciNova, Inc. for you?

High Risk, Medium Return

Absolute
Risk Adjusted
Volatility
MediciNova, Inc.
-2.01%
0.13
69.07%
S&P 500
13.68%
0.71
19.28%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
7.11%
EBIT Growth (5y)
1.24%
EBIT to Interest (avg)
-12.38
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.73
Sales to Capital Employed (avg)
0.01
Tax Ratio
0.05%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
11.60%
ROCE (avg)
0
ROE (avg)
0
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.72
EV to EBIT
-3.07
EV to EBITDA
-3.08
EV to Capital Employed
3.71
EV to Sales
40.76
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-121.03%
ROE (Latest)
-28.85%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bearish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
No Trend
Mildly Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

12What is working for the Company
NET SALES(9M)

At USD 0.41 MM has Grown at inf%

RAW MATERIAL COST(Y)

Fallen by -313% (YoY

OPERATING PROFIT(Q)

Highest at USD -3.09 MM

PRE-TAX PROFIT(Q)

Highest at USD -2.8 MM

NET PROFIT(Q)

Highest at USD -2.8 MM

EPS(Q)

Highest at USD -0.06

-3What is not working for the Company
ROCE(HY)

Lowest at -25.5%

CASH AND EQV(HY)

Lowest at USD 63.37 MM

Here's what is working for MediciNova, Inc.

Net Sales
At USD 0.41 MM has Grown at inf%
Year on Year (YoY)
MOJO Watch
Sales trend is very positive

Net Sales (USD MM)

Operating Profit
Highest at USD -3.09 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (USD MM)

Pre-Tax Profit
Highest at USD -2.8 MM
in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (USD MM)

Net Profit
Highest at USD -2.8 MM
in the last five periods
MOJO Watch
Near term Net Profit trend is positive

Net Profit (USD MM)

EPS
Highest at USD -0.06
in the last five periods
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (USD)

Raw Material Cost
Fallen by -313% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for MediciNova, Inc.

Cash and Eqv
Lowest at USD 63.37 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is deteriorating

Cash and Cash Equivalents